“Association Between Interleukin-6 Levels, Rituximab Response, and Disease Activity in Patients With Rheumatoid Arthritis”. 2025. Al Mustansiriyah Journal of Pharmaceutical Sciences 25 (3): 455-61. https://doi.org/10.32947/ajps.v25i3.1225.